Helicobacter Pylori Infection; Short Note for Undergraduate Medical Student
Helicobacter pylori Infection
By: Hariz Hizami Hatta
1. Characteristics:
a)
gram negative
b)
microaerophilic (require
environment with lower level of oxygen)
c)
bacilli (cork-crew shape)
d)
has flagella (motility)
e)
ROT: faecal-oral
2. Disease associated with H. pylori:
a)
chronic gastritis
b)
peptic ulcer disease
·
It has lipopolysaccharide
(LPS) on cell surface that are less mitogenic, pyrogenic and toxic compare to
other Enterobacteriaceae
·
Has ability to neutralize gastric acid by secreting
urease that will be converted into ammonia (alkaline), subsequently can
withstand the acidity and continue causing inflammation to the epithelial cells
3. Investigations of H.
pylori infection:
Non-invasive
test;
To
detect bleeding
a)
CBC
b)
Rectal exam
c)
Faecal Occult Blood Test
(FOBT) – To check blood in stool that cannot be seen with naked eyes. Faces
smeared on treated paper, which reacts to hydrogen peroxide. If blood is
present, the paper turns blue.
To
detect the presence of H. pylori
a)
Urea breath test
-
2 weeks before test, pt
must discontinue taking any antibiotics, PPIs
-
procedure: pt swallow
substance containing urea treated with carbon atoms. If there’s H. pylori
infection, the urea will be converted
into carbon dioxide that will be detected and recorded in pt’ s exhaled
breath after 10 minutes
-
pt need to fast overnight and
baseline breath sample is obtained first. result will be based on increase of
carbon dioxide in the breath
b)
Stool test
-
detect genetic
fingerprints of H. pylori
-
can be as accurate as the
breath test
Indications:
·
patient with dyspepsia +
history of active ulcers + other RFs
·
smokers with persistent
pain on an empty stomach
·
regular NSAIDs users with
dyspepsia
·
risk for stomach cancer +
dyspepsia
·
patient with dyspepsia
longer than 4 weeks
Invasive
test:
a)
Endoscopy (oesophagogastroduodenoscopy, OGD)
Thins tube tipped with a tiny video camera to evaluate the oesophagus,
stomach and duodenum. Most commonly combined with biopsy to look for peptic
ulcers, bleeding, cancer or to confirm presence of H. pylori.
Indicated for pt with dyspepsia as well as RF for ulcers, stomach cancer
or both. Pt with unexplained weight loss, dysphagia and anaemia
b)
Rapid urease test
-
Campylobacter-like
organism (CLO test)
-
rapid detection of ammonia
after converted from urea by H. pylori using urease
-
reagent that contain urea
and phenol red (weak acid) will react with tissue biopsy specimen that contain
H. pylori. H. pylori convert urea into ammonia that is alkaline with urease
enzyme and will neutralize the phenol red (weak acid)
-
colour change from yellow to pinkish or purplish
§ can be false negative with recent use of PPIs, antibiotics or bismuth
compounds
c)
Blood tests
To measure antibodies to H. pylori. Use ELISA
Diagnostic accuracy 80 to 90%
d)
Histological identification
Can use Warthin-Starry, H&E and Giemsa stains. To exclude malignancy
e)
H. pylori culture
f)
Molecular methods
g) PCR
4. Virulence
factors
a)
Urease enzyme
-
convert urea into
bicarbonate and ammonia (alkaline) that can neutralize gastric acid
-
can be detected in breath
test
b)
Inability of body’s
natural defence
-
WBC, Killer T cells etc.
cannot reach the bacterium in the mucus lining of stomach
c)
Adhesins (LPS)
-
adhere (bind) to specific
receptors on epithelial cells
d)
Flagella for motility
e)
Exotoxin (Vacuolating
toxin VacA) –
gastric mucosal injury
f)
Effectors (CagA) – actin remodelling,
IL-8 induction, host cell growth and apoptosis inhibition
g)
Nutrient supply
Virulence
Factors |
Descriptions |
Flagella |
Motility, allow rapid movement in viscous solutions
such as the mucus layer |
Urease |
Metabolize urea to produce ammonia and carbon dioxide.
Withstand the acidity of stomach via neutralization |
Adhesins |
Adheres to receptors in the gastric epithelium by
means of adhesins |
Vacuolating Cytotoxin (VacA) |
·
Able to induce vacuole
formation in eukaryotic cells, membrane channel formation leading to release
of cytochrome c release from mitochondria eventually apoptosis of cells. ·
Pro-inflammatory
response and inhibit T cell activation |
Cytotoxin-associated gene A (CagA) |
·
Alters intracellular
signal transduction pathways that facilitate the malignant transformation of
gastric epithelial cells ·
Increase IL-8 secretion
which predisposes to genetic instability and carcinogenesis |
5.
Treatment
·
Triple
therapy (PPIs + 2 antibiotics)
-
antibiotics:
amoxicillin, clarithromycin, metronidazole, tetracycline
-
PPIs:
reduce gastric acid secretion in the stomach
·
Histamine
(H2) receptors blockers; reduce acid secretion
·
Bismuth
subsalicylate: anti diarrheal (common OTC medication)
Comments
Post a Comment